
I really enjoyed this "Snippet" about our recent paper describing PDAR. lifescienceeditors.com/2025/…

A Laboratory of Systems Pharmacology

I really enjoyed this "Snippet" about our recent paper describing PDAR. lifescienceeditors.com/2025/…

BE Seminar Series returns with @TheLeeLab, @UMassChan “Life, Death, and the Discovery of the Pol II Degradation-dependent Apoptotic Response (PDAR)” 32-141, 4p, 10/2 ow.ly/WiQh50X5aLh

Now online! RNA Pol II inhibition activates cell death independently from the loss of transcription dlvr.it/TMWhrz

I don't post in this space much anymore... I can be found on other platforms using the same handle.

The answer is about analytical resolution!!! The way we measure drug responses makes drug-induced growth rates and death rates very clear. More conventional approaches just can't see these distinctions clearly, masking this crazy phenotype. (8/end)

There is lots of cool stuff to work on moving forward, but I'll end by highlighting why we found this, when so many others probably could have but didn't notice. (7/n)

We identified many clinically used drugs that owe their lethality to a PDAR-dependent cell death. Many of these are not conventionally thought of as transcriptional inhibitors! (6/n)

We did a genetic screen to identify regulators of this death response... We call this response PDAR: The Pol II Degradation-dependent Apoptotic Response. (5/n)

It's challenging to uncouple Pol II expression from Pol II activity (Pol II activity creates Pol II expression) but we managed! We did many things, but the most notable is that we suppressed lethality caused by loss of Pol II by giving cells a non-functional form of Pol II! (4/n)

We spent a lot of time trying to rationalize this through the decay rates of certain transcripts/proteins, but it never worked. The big 'ah-ha' was when we noticed that variation in death kinetics was perfectly coupled to variation in theloss of the inactive form of Pol II (3/n)

we first noticed that death following loss of Pol II is only apoptotic. This is surprising, considering that there are many other ways for cells to "waste away" in the absence of gene expression... but, cells that can't do apoptosis just sit there. pretty happily in fact (2/n)

We just posted a preprint about a death mechanism that we find truly surprising. When you turn off transcription, cells die (duh!) but did you know this happens due to loss of Pol II itself, not loss of Pol II activity! preprint here and a thread (1/n): biorxiv.org/content/10.1101/…

Please RT! We are officially accepting applications to the @UW Pharmacology PhD program! Are you excited about doing a PhD in a cutting-edge, multidisciplinary community that spans all levels of pharmacology? Come join us! Deadline is Dec. 1. pharmacology.uw.edu/graduate…

The SACB Abstract deadline is this Friday. This is an awesome community and always a very engaging meeting. Join us in Colorado this February!
Abstracts are due this Friday for #SACB2025! A great meeting for those who are employing systems approaches in cancer. We have an incredible array of speakers and a fantastic new location near Denver, Colorado.

Systems approaches to cancer biology meeting (SACB2025) is coming up! The abstract deadline and application to be part of our SACB 2025 Scholar program is Friday, November 1. Check out the details at sacbmeeting.org

Thrilled to share our latest story on 5-FU inducing RNA damage during ribosome biogenesis - cell.com/cell-reports-medici…. The whole thing started when Karl and Jung-Kuei were trying to figure out hiow limiting dNTPS skewed DNA repair. Never thought it would be RNA and tge ribosome!